Cleared Traditional

VECTOR(TM) AMBULATORY DRUG DELIVERY SYSTEM (K943591) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K943591 · Infusion Technology Intl. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
338d
Days
Class 2
Risk

K943591 is an FDA 510(k) clearance for the VECTOR(TM) AMBULATORY DRUG DELIVERY SYSTEM. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Infusion Technology Intl. (Danvers, US). The FDA issued a Cleared decision on June 28, 1995 after a review of 338 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Infusion Technology Intl. devices

Submission Details

510(k) Number K943591 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 1994
Decision Date June 28, 1995
Days to Decision 338 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
209d slower than avg
Panel avg: 129d · This submission: 338d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 208
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K943591.
SNAPDOSE DEVICE
K955410 · Abbott Laboratories · May 1996
LIFESHIELD LUER ACTIVATED VALVE MALE ADAPTER PLUG
K953584 · Abbott Laboratories · Oct 1995
SOLUTION SET WITH 1.2 MICRON AIR ELIMINATING FILTER
K952074 · Baxter Healthcare Corp · Jul 1995
BECTON DICKINSON INTERLINK(TM) LEVER/Y LOCK
K940697 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Aug 1994
PROVIDER PUMP SET W/INFUSION CARTRIDGE
K934513 · Abbott Laboratories · Jul 1994
ENERGIZED DRUG CONTAINER SYSTEM
K934119 · Abbott Laboratories · Jun 1994